The promise of genetically engineered mice for cancer prevention studies

被引：64

作者：

Green, JE ^{[1
]}

Hudson, T ^{[1
]}

机构：

[1] NCI, Transgen Oncogenesis Grp, Lab Cell Regulat & Carcinogenesis, Bethesda, MD 20892 USA

来源：

NATURE REVIEWS CANCER | 2005年 / 5卷 / 03期

关键词：

D O I：

10.1038/nrc1565

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Sophisticated genetic technologies have led to the development of mouse models of human cancers that recapitulate important features of human oncogenesis. Many of these genetically engineered mouse models promise to be very relevant and relatively rapid systems for determining the efficacy of chemopreventive agents and their mechanisms of action. The validation of such models for chemoprevention will help the selection of appropriate agents for large-scale clinical trials and allow the testing of combination therapies.

引用

页码：184 / 198

页数：15

共 133 条

[1] Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma [J].

Aguirre, AJ ;

Bardeesy, N ;

Sinha, M ;

Lopez, L ;

Tuveson, DA ;

Horner, J ;

Redston, MS ;

DePinho, RA .

GENES & DEVELOPMENT, 2003, 17 (24) :3112-3126

[2] Dietary depletion of vitamin E and vitamin A inhibits mammary tumor growth and metastasis in transgenic mice [J].

Albright, CD ;

Salganik, RI ;

Van Dyke, T .

JOURNAL OF NUTRITION, 2004, 134 (05) :1139-1144

[3] Cancer resistance genes in mice: models for the study of tumour modifiers [J].

Balmain, A ;

Nagase, H .

TRENDS IN GENETICS, 1998, 14 (04) :139-144

[4] Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin [J].

Barnes, CJ ;

Lee, M .

GASTROENTEROLOGY, 1998, 114 (05) :873-877

[5] Sulindac suppresses tumorigenesis in the Min mouse [J].

BeazerBarclay, Y ;

Levy, DB ;

Moser, AR ;

Dove, WF ;

Hamilton, SR ;

Vogelstein, B ;

Kinzler, KW .

CARCINOGENESIS, 1996, 17 (08) :1757-1760

[6] Pathology of mouse models of intestinal cancer: Consensus report and recommendations [J].

Boivin, GP ;

Washington, K ;

Yang, K ;

Ward, JM ;

Pretlow, TP ;

Russell, R ;

Besselsen, DG ;

Godfrey, VL ;

Doetschman, T ;

Dove, WF ;

Pitot, HC ;

Halberg, RB ;

Itzkowitz, SH ;

Groden, J ;

Coffey, RJ .

GASTROENTEROLOGY, 2003, 124 (03) :762-777

[7] Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model [J].

Bok, RA ;

Hansell, EJ ;

Nguyen, TP ;

Greenberg, NM ;

McKerrow, JH ;

Shuman, MA .

PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (04) :272-280

[8] EFFECT OF AN AROMATASE INHIBITOR, 4-HYDROXY-4-ANDROSTENE-3,17-DIONE, ON ESTROGEN-DEPENDENT PROCESSES IN REPRODUCTION AND BREAST-CANCER [J].

BRODIE, AMH ;

SCHWARZEL, WC ;

SHAIKH, AA ;

BRODIE, HJ .

ENDOCRINOLOGY, 1977, 100 (06) :1684-1695

[9]

Calvo A, 2002, CANCER RES, V62, P3934

[10] Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin [J].

Calvo, A ;

Yokoyama, Y ;

Smith, LE ;

Ali, I ;

Shih, SC ;

Feldman, AL ;

Libutti, SK ;

Sundaram, R ;

Green, JE .

INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (03) :224-234

← 1 2 3 4 5 6 7 8 9 10 →